Sumatriptan and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Gliclazide (gliclazide). Common drug interactions include vomiting among females and mental disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Gliclazide. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

On Jul, 10, 2026

22 people who take Sumatriptan and Gliclazide together, and have interactions are studied.

Sumatriptan and Gliclazide drug interactions.

What are the common drug interactions of Sumatriptan and Gliclazide, by gender? *:

female:

Vomiting
Anuria (failure of the kidneys to produce urine)
Breakthrough pain
Drug ineffective
Headache (pain in head)
Neuropathy peripheral (surface nerve damage)
Poor peripheral circulation
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Weight increased

male:

Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Craniocerebral injury (injury to cranium and brain)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Loss of consciousness
Memory impairment
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Schizoaffective disorder (a mental disorder characterized by disordered thought)
Fall
Haemorrhage (bleeding)

What are the common drug interactions of Sumatriptan and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Drug ineffective
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Loss of consciousness
Stress

50-59:

Vomiting
Anuria (failure of the kidneys to produce urine)
Constipation
Creatinine renal clearance decreased
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hypophagia (reduced food intake)
Kidney transplant rejection
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)
Poor peripheral circulation

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 63.64%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 45.45%
Pain: 3 people, 13.64%
Drowsiness: 3 people, 13.64%
Neuropathy Peripheral (surface nerve damage): 2 people, 9.09%
Asthma: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously